Effects of medicaid access restrictions on statin utilisation for patients treated by physicians practising in poor and minority neighbourhoods

PharmacoEconomics

Volumn 24, Issue SUPPL.3, 2006, Pages 41-53

  Headen Jr , Alvin E ^a   Masia, Neal A ^b   Axelsen, Kirsten J ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CLASSIFICATION; CLINICAL PRACTICE; DEMOGRAPHY; DRUG USE; ECONOMICS; HEALTH CARE DELIVERY; HUMAN; MEDICAID; PATIENT; PHARMACOECONOMICS; POVERTY; RETROSPECTIVE STUDY; STANDARD; STATISTICS; UNITED STATES;

DRUG UTILIZATION REVIEW; ECONOMICS, PHARMACEUTICAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEDICAID; PATIENTS; PHYSICIAN'S PRACTICE PATTERNS; POVERTY AREAS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SOUTHEASTERN UNITED STATES; TEXAS;

EID: 34250348398     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/00019053-200624003-00004     Document Type: Article

References (21)

1. Crowley JS, Ashner D, Elam L. State Medicaid outpatient prescription drug policies: findings from a national survey, 2005 update. Kaiser Commission on Medicaid and the Uninsured. October 2005 [online]. Available from URL: www.kff.org. [Accessed: 2005 Oct].
2. Bishop G. One state's Medicaid managed care formulary operations: a look at Pennsylvania, 2001-2002. March 2005. Kaiser Commission on Medicaid and the Uninsured [online]. Available from URL: www.kff.org. [Accessed 2005 Sep].
3. Bernasek C, Farkas J, Felman H, et al. Case study: Michigan's Medicaid prescription drug benefit. Kaiser Commission on Medicaid and the Uninsured. January 2003 [online]. Available from URL: www.kff.org. [Accessed 2005 Sep].
4. Ketchum, JD, Epstein AJ. The incidence of Medicaid preferred drug lists. Pharmacoeconomics 2006; in press
5. National Center for Health Statistics. Health, United States, 2005: with chartbook on trends in the health of Americans. Hyattsville, MD: National Center for Health Statistics 2005
6. Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in healthcare. Washington, DC: Urban Institute 2003
7. Skinner J, Chandra A, Staiger D, et al. Mortality after acute myocardial infarction in hospitals that disproportionately treat black patients. Circulation 2005; 112: 2634-41 (Pubitemid 41532600)
8. Konety SH, Vaughan Sarrazin MS, Rosenthal GE. Patient and hospital differences underlying racial variation in outcomes after coronary artery bypass graft surgery. Circulation 2005; 111: 1210-6 (Pubitemid 40389083)
9. Barnato AE, Lucas FL, Staiger D, et al. Hospital-level racial disparities in actue myocardial infarction treatment and outcomes. Med Care 2005; 43: 308-19 (Pubitemid 40515620)
10. Baicker K, Chandra A, Skinner JS. Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med 2005; 48 Suppl: 42-53
11. Baicker K, Chandra A, Skinner JS, et al. Who you are and where you live: how race and geography affect the treatment of Medicare beneficiaries. Health Affairs 2004; VAR: 33-44
12. Coughlin TA, Long SK, Shen YC. Assessing access to care under Medicaid: evidence for the nation and 13 states. Health Affairs 2005; 24: 1073-83 (Pubitemid 41058608)
13. US Census Bureau. Income, poverty and health insurance coverage in the United States: 2004. Department of Commerce; August 2005
14. Headen A, Masia N. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities. Am J Managed Care 2005; 11: S21-6
15. Alabama Medicaid Agency. Pharmacy and Therapeutics Committee Preferred Drug List. Available from URL: http://www.medicaid.alabama.gov/documents/3J-5c- 5d-4-PDLfinal.Dec10.2003.pdf. [Accessed 2006 January]
16. Florida Agency for Health Care Administration. Medicaid Pharmacy Services. Available from URL: http://www. fdhc.state.fl.us/Medicaid/Prescribed- Drug/pharm-thera/fmpdl.shtml. [Accessed 2005 December]
17. Georgia Health Partnership. Medicaid, Other Pharmacy Documents. Available from URL: https://www.ghp.georgia. gov/wps/output/en-US/public/Provider/ Pharmacy Services/MedPrefDrugList-alphByDrugNameold2. pdf. [Accessed 2005 December]
18. Texas Health and Human Services Commission. Preferred Drug List Program. Available fromURL: http://www.hhsc. state.tx.us/HCF/vdp/pt/PDL-Program.html. [Accessed 2005 November]
19. Virginia Department of Medical Assistance Services. Pharmacy Services, Preferred Drug List. Available from URL: http://www.dmas.virginia.gov/pharm-pdl- advisory- group.htm#Documents. [Accessed 2005 December]
20. West Virginia Department of Health & Human Services. Bureau for Medicaid Services Preferred Drug List. Available from URL: http://www.wvdhhr. org/BMS/sPharmacy/PDL/bms-PDL-main.asp. [Accessed 2005 December]
21. Kaiser Family Foundation. State health facts [online]. Available from URL: http://www.statehealthfacts.org. [Accessed 2005 Dec].